Business Wire

COLOGNE, Germany--(BUSINESS WIRE)-- SoSafe, Europe’s largest security awareness and human risk management vendor, has appointed four new Executive Advisors. The advisors, comprised of industry experts and technology investors, will provide advice and strategic counsel to the SoSafe leadership team on its ambitious plans to expand their category and product leadership.

This press release features multimedia. View the full release here: ... (continue reading...)

PLANTATION, Fla.--(BUSINESS WIRE)-- Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, has released its financial results for the first quarter of fiscal year 2024 ended April 28, 2024.

Fiscal Q1 2024 Highlights:

• Net sales of $2.88 billion increased 3.1 percent year over year
• Gross margin of 29.7 percent increased 130 basis points year over year
• Net income of $66.9 million, including share-based... (continue reading...)

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)-- Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, announced initial data from the Phase 1 MINOTAUR study evaluating lunresertib (RP-6306) in combination with FOLFIRI for the treatment of advanced solid tumors has been selected for a poster presentation at the European Society of Medical Oncology (ESMO) Gastrointestinal (GI) Cancers Congress... (continue reading...)

VUZE 2.0 provides much-extended interoperability and functionality; like VUZE 1.0, requires only a 2D C-arm and PC in the OR -- no cameras, markers, references or tool add-ons

RA’ANANA, Israel--(BUSINESS WIRE)-- VUZE Medical, a privately-held company aiming to transform intra-operative guidance in spinal interventions currently aided only by X-ray, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its second-generation VUZE... (continue reading...)

BRISBANE, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA), The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in two upcoming investor conferences.

CareDx’s management is scheduled to present at the:

• Jefferies Global... (continue reading...)